Johnson & Johnson JNJ
NYSE JNJ
$261.49 +5.00 (+1.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Consolidated Net Income (2009 - 2026)

Updated

Johnson & Johnson's Consolidated Net Income came in at $5.53 billion for Q2 2026, down 0.1% from $5.54 billion a year earlier but up 5.7% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Consolidated Net Income (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 28, 2026, Johnson & Johnson reported Consolidated Net Income of $21.04 billion, down 7.2% year-over-year; for FY2025, it came in at $26.8 billion, up 90.6% from FY2024.

  • Consolidated Net Income carries a four-year compound annual growth rate of 16.2% (FY2021 to FY2025).
  • Going back by year, Consolidated Net Income was $14.07 billion in FY2024 (-60.0%), $35.15 billion in FY2023 (+95.9%), $17.94 billion in FY2022 and $14.71 billion in FY2021.
  • The five-year range for quarterly Consolidated Net Income is -$68 million (Q1 2023) to $26.03 billion (Q3 2023).
  • Year-over-year, Consolidated Net Income increased in four of the last eight quarters, with growth averaging 29.9%.
  • The fastest year-over-year change in Consolidated Net Income over five years came in Q1 2025 (growth of 237.9%), and the weakest in Q3 2024 (a decline of 89.6%).
  • Business Quant data shows JNJ's Consolidated Net Income at $5.24 billion (Q1 2026), $5.12 billion (Q4 2025) and $5.15 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 5.53 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 3.62 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 2.51 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -10.50 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn -237.00 Mn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 5.53 Bn
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 29, 2024 3.43 Bn
Sep 29, 2024 2.69 Bn
Jun 30, 2024 4.69 Bn
Mar 31, 2024 3.26 Bn
Dec 31, 2023 4.05 Bn
Oct 1, 2023 26.03 Bn
Jul 2, 2023 5.14 Bn
Apr 2, 2023 -68.00 Mn
Jan 1, 2023 3.52 Bn
Oct 2, 2022 4.46 Bn
Jul 3, 2022 4.81 Bn
Apr 3, 2022 5.15 Bn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn
API Access

Johnson & Johnson Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=JNJ&period=max&api_key=YOUR_API_KEY